在患有IL-10Rβ缺乏症的患者中成功使用Anakinra:一个案例报告
Selcuk Dogan1, Ridvan Selen1, Ferda Ozbay Hosnut2
1Department of Pediatric Immunology and Allergy, Dr. Sami Ulus Children's Health and Diseases Training and Research Hospital, Ankara, Turkiye.
Pediatric allergy, immunology, and pulmonology
|February 14, 2025
概括
介素-10受体β (IL-10Rβ) 缺乏导致严重的早期发病性炎症性肠病 (IBD). 阿纳金拉治疗改善了症状,使患者能够成功地进行造血干细胞移植 (HSCT).
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 介质素-10 (IL-10) 对于免疫系统的平衡至关重要,尤其是在肠道中.
- 缺陷IL-10信号传递,如IL-10受体β (IL-10Rβ) 缺乏,与早期发病的炎症性肠病 (IBD) 有关.
- 这些疾病往往对标准治疗有抗性.
研究的目的:
- 报告一种IL-10Rβ缺乏症病例,呈现出严重的,早期发病的IBD.
- 评估阿纳金拉作为血造干细胞移植 (HSCT) 的桥梁疗法的疗效.
- 强调基因检测对诊断和治疗的重要性.
主要方法:
- 一个1.5个月大的男婴患有严重的IBD症状的临床病例报告.
- 基因检测证实IL10RB基因中的同卵性缺失.
- 用阿纳金拉 (互乐金-1受体对抗剂) 治疗,其次是全基性HSCT.
主要成果:
- 患者出现了发烧,吐,营养不良和败血症.
- 阿纳金拉的使用导致了显著的临床改善,包括体重增加和症状缓解.
- 从与HLA匹配的相关捐赠者进行了成功的HSCT.
结论:
- 缺少IL-10Rβ会导致严重的,耐火的早期发病性IBD.
- 亚纳金拉在治疗炎症和改善结果方面表现有前途,作为通往HSCT的桥梁.
- 早期遗传诊断和针对性疗法如anakinra对于这种具有挑战性的疾病至关重要.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
110
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
110
01:24T Cell Types and Functions
897
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
897
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
135
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
135
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K